过去一年中添加的文章,按日期排序
1268 Eruptive keratoacanthomas secondary to nivolumab therapy
E Olsen, S Svoboda, M Montanez-Wiscovich, S Saikaly - 2023 - jitc.bmj.com
222 天前 - … , with 22 reported cases of keratoacanthoma resulting from PD-1/PD-L1 inhibitor
use. Most of these were treated successfully with topical and intralesional corticosteroids, …
use. Most of these were treated successfully with topical and intralesional corticosteroids, …
Pemphigus: current and future treatment strategies
J Kussini, T Kaisers, SS AM, R Eming… - Dermatologie …, 2023 - europepmc.org
224 天前 - … Pemphigus diseases are a group of organ-specific autoimmune … therapy of
pemphigus diseases, a systemic therapy is recommended. Initially, high-dose, oral corticosteroids in …
pemphigus diseases, a systemic therapy is recommended. Initially, high-dose, oral corticosteroids in …
Anti-laminin 332 antibodies in graft-versus-host disease-associated bullous pemphigoid after allogeneic peripheral blood stem cell transplantation
Y Hida, R Kageji, H Bekku, N Ishii - Dermatology Online Journal, 2023 - escholarship.org
228 天前 - … of subepidermal autoimmune blistering diseases (SABD) … We tried a combination
regimen of topical corticosteroids (… the use of combination regimens of topical corticosteroids …
regimen of topical corticosteroids (… the use of combination regimens of topical corticosteroids …
Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters
D Han, AY Lee, T Kim, JY Choi, MY Cho… - The Journal of …, 2023 - Am Soc Clin Investig
243 天前 - … autoimmune bullous disease mediated by antidesmoglein autoantibodies, can
be controlled with systemic medication like rituximab and high-dose systemic corticosteroids …
be controlled with systemic medication like rituximab and high-dose systemic corticosteroids …
Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid
FM Margiotta, C Fidanzi, M Bevilacqua… - Skin Research and …, 2023 - ncbi.nlm.nih.gov
250 天前 - … Bullous pemphigoid (BP) is an autoimmune disease characterized by the
occurrence of subepidermal blistering … by oral corticosteroids, while 2nd line therapy includes …
occurrence of subepidermal blistering … by oral corticosteroids, while 2nd line therapy includes …
S2542 Case of Severe Multifactorial Diarrhea in the Setting of Clostridioides difficile: Infection and Lymphocytic Colitis Unresponsive to Budesonide
H Gosnell, K Tessiatore… - Official journal of the …, 2023 - journals.lww.com
253 天前 - … with budesonide and prior failed steroid therapy, mesalamine was … use, CDI,
inflammation from chronic diarrhea, and possibly autoimmune-related given bullous pemphigoid. …
inflammation from chronic diarrhea, and possibly autoimmune-related given bullous pemphigoid. …
2179P Prospective monitoring of autoimmune events in cancer immunotherapy patients: A report on the first 658 patients in the PRAISE study
E Sebbag, N Cloarec, I Monnet, A Najem… - Annals of …, 2023 - annalsofoncology.org
253 天前 - … other autoimmune manifestations (23). 40 patients discontinued immunotherapy due
to irAE, and treatment with corticosteroids … (n=1) were also used to treat specific irAE. One …
to irAE, and treatment with corticosteroids … (n=1) were also used to treat specific irAE. One …
S2722 Bullous Pemphigoid with Esophageal Involvement: A Rare Manifestation
D Ukwade, M Siegel, K Lakhoo… - Official journal of the …, 2023 - journals.lww.com
253 天前 - … therapy. Discussion: Although esophageal BP is rare, BP is the most common
autoimmune blistering disease. BP … symptoms and the mainstay therapy is steroids (see Figure 1). …
autoimmune blistering disease. BP … symptoms and the mainstay therapy is steroids (see Figure 1). …
[HTML][HTML] Retrospective analysis of autoimmune bullous diseases in Middle Franconia
L Sollfrank, V Schönfelder, M Sticherling - Frontiers in Immunology, 2023 - frontiersin.org
255 天前 - … In our study, the majority of patients received internal systemic therapy with
corticosteroids. Although these show rapid therapeutic success, they are accompanied by …
corticosteroids. Although these show rapid therapeutic success, they are accompanied by …
[PDF][PDF] P14 A rare adverse event of eosinophilic fasciitis secondary to immune checkpoint inhibitor therapy
S Byravan, L Dolan, T Blake - Rheumatology Advances in …, 2023 - academic.oup.com
256 天前 - … Though our patient initially flared upon steroid reduction, a slower taper and addition
of … along with offering insight to the pathophysiology of manifesting autoimmune disease. …
of … along with offering insight to the pathophysiology of manifesting autoimmune disease. …